文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒肝肾功能剂量调整

甲氨蝶呤致肾毒性与暴露阈值:PCNSL群体PKPD模型

Methotrexate-Induced Nephrotoxicity and Exposure Thresholds in Primary Central Nervous System Lymphoma: A Population PKPD Model.
PubMed 文献 · Clin Pharmacol Ther · 2026-05-04

该研究基于743例中国成人PCNSL患者的5918份血药浓度样本,建立群体PKPD模型预测甲氨蝶呤相关肾毒性。血红蛋白为最显著预测因子,并构建了按毒性分级和个体风险耐受定制的浓度阈值曲线。以10%的≥2级肾毒性风险为监测阈值,24、48、72小时MTX浓度阈值分别为9.71、0.81、0.26 μmol/L。

要点

  • 血红蛋白越高,肾损伤易感性越低。
  • 以10%≥2级肾毒性风险为阈值,24/48/72h浓度阈值为9.71/0.81/0.26 μmol/L。
  • 该模型可作为TDM的探索性补充工具,用于早期识别肾损伤。

核心结论

  • MTX线性模型在预测性能与临床可行性间取得最佳平衡,可用于PCNSL患者HD-MTX相关肾毒性的个体化风险预测。

研究设计与样本

  • 基于743例中国成人PCNSL患者的5918份血浆浓度样本进行群体PKPD分析,采用非线性混合效应模型建立由MTX、7-羟基-MTX或其联合驱动的毒效学结构模型。

主要发现

  • 所有毒效学模型预测性能相当,最终选择MTX线性模型。
  • 协变量分析显示血红蛋白是肾损伤易感性的最显著预测因子,血红蛋白越高肾损伤易感性越低。
  • 构建了暴露-毒性概率曲线,可按毒性分级(1级 vs ≥2级)和个体风险耐受确定动态浓度阈值。

关键数值与推荐

  • 以10%的≥2级肾毒性风险概率作为安全监测阈值时,24、48、72小时对应的MTX浓度阈值分别为9.71、0.81、0.26 μmol/L。

临床怎么用

  • 该定量框架可作为治疗药物监测的探索性补充工具,辅助早期识别肾功能正常至轻度受损的PCNSL患者中的MTX相关肾损伤。

局限性

  • 该框架为探索性工具,需进一步验证其临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-dose methotrexate (HD-MTX)-induced nephrotoxicity remains a critical clinical challenge in primary central nervous system lymphoma (PCNSL) treatment, yet quantitative tools for individualized risk prediction are currently lacking. Here, a population pharmacokinetic/pharmacodynamic analysis was performed using 5,918 plasma concentration samples from 743 Chinese adult patients. Nonlinear mixed-effects modeling was employed to establish toxicodynamic structural models driven by MTX alone, 7-Hydroxy-MTX alone, or their combination. Although all models exhibited comparable predictive performance, the MTX linear model was selected as it offered the optimal balance between predictive performance and clinical feasibility. Covariate analysis identified hemoglobin as the most significant predictor, with higher levels correlating with reduced susceptibility to renal injury. To facilitate clinical translation, exposure-toxicity probability curves were constructed, enabling clinicians to identify dynamic concentration thresholds tailored to specific toxicity grades (Grade 1 vs. ≥2 nephrotoxicity) and individualized risk tolerance. Using a 10% risk probability for Grade ≥2 nephrotoxicity as the safety monitoring threshold, the corresponding MTX concentration thresholds at 24, 48, and 72 h were 9.71, 0.81, and 0.26 μmol/L, respectively. This quantitative framework serves as an exploratory tool to complement therapeutic drug monitoring, assisting in the early identification of MTX-induced renal injury among PCNSL patients with normal to mildly impaired renal function.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wu R, Sun H, Li Y, et al. Methotrexate-Induced Nephrotoxicity and Exposure Thresholds in Primary Central Nervous System Lymphoma: A Population PKPD Model. Clin Pharmacol Ther. 2026. PMID: 42083006. doi:10.1002/cpt.70305

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。